During the meeting, the team members agreed to define Kannoli Pharma as a life sciences company with a focus on the High Medical Use of specialized cannabinoids & terpenes used in supportive medicine.
Supportive medicine includes:
- Oncology
- Palliative care
- Lowering side effects on the chemotherapy
Neuroscience
- Epilepsy
- Alzheimer’s
- Multiple Sclerosis
- Anxiety
- Depression
The team has also set the strategy in 3 stages.
Stage 1 is to extract to off-takers.
Stage 2 will be 3rd party extraction.
Stage 3 will be Kannoli Pharma – High Medical Use specialized medical cannabis.
The team agreed to have Credibility, Seniority, Empathy as the core values of Alkannoli.
